Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes-Reference-Cited by-同舟云学术

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Published:2020-03-31 Issue:5 Volume:17 Page:259-270
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Meeks Joshua J.,Al-Ahmadie Hikmat^ORCID,Faltas Bishoy M.^ORCID,Taylor John A.^ORCID,Flaig Thomas W.,DeGraff David J.,Christensen Emil^ORCID,Woolbright Benjamin L.,McConkey David J.,Dyrskjøt Lars^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/s41585-020-0304-1.pdf

Reference133 articles.

1. McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613–628 (2017).

2. Lamy, P. et al. Paired exome analysis reveals clonal evolution and potential therapeutic targets in urothelial carcinoma. Cancer Res. 76, 5894–5906 (2016).

3. da Costa, J. B. et al. Molecular tumor heterogeneity in muscle invasive bladder cancer: biomarkers, subtypes, and implications for therapy. Urol. Oncol. https://doi.org/10.1016/j.urolonc.2018.11.015 (2018).

4. Warrick, J. I. et al. Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants. Eur. Urol. 75, 18–22 (2019).

5. Ma, G. et al. Precision medicine and bladder cancer heterogeneity. Bull. Cancer 105, 925–931 (2018).

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics;Neoplasia;2024-11

2. Biomarkers associated with survival in patients with platinum-refractory urothelial carcinoma treated with paclitaxel;Urologic Oncology: Seminars and Original Investigations;2024-11

3. Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology;European Urology;2024-09

4. Comparative analysis of non-coding and coding DNA mutations in flat urothelial lesions: biological implications and insights;Virchows Archiv;2024-08-21

5. A metabolic reprogramming-related gene signature correlates with prognosis and proliferation of BLCA;Discover Oncology;2024-08-08